Clearstead Advisors, LLC Sana Biotechnology, Inc. Transaction History
Clearstead Advisors, LLC
- $7.4 Billion
- Q3 2025
A detailed history of Clearstead Advisors, LLC transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 6,897 shares of SANA stock, worth $27,519. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,897
Previous 7,316
5.73%
Holding current value
$27,519
Previous $19,000
26.32%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SANA
# of Institutions
197Shares Held
122MCall Options Held
194KPut Options Held
353K-
Flagship Pioneering Inc. Cambridge, MA25MShares$99.8 Million32.83% of portfolio
-
Black Rock Inc. New York, NY11MShares$44.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$41.7 Million0.0% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A610.2MShares$40.6 Million0.03% of portfolio
-
State Street Corp Boston, MA6.68MShares$26.7 Million0.0% of portfolio
About Sana Biotechnology, Inc.
- Ticker SANA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 190,232,000
- Market Cap $759M
- Description
- Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...